The European Medicines Agency plays a central role in the regulation of Europe’s medicines supply. The Coronavirus pandemic has led the EU to expand and strengthen the EMA’s powers in pharmaceutical policy. This is happening against the backdrop of globalization, where the EMA is both influenced by and impacting on pharmaceutical policy far beyond its borders. This seminar unpacks and discusses these issues from the perspective of law and governance.
Dr. Katrina Perehudoff, Senior Research Fellow, Law Centre for Health and Life, University of Amsterdam
Dr. Sabrina Röttger-Wirtz, Assistant Professor of EU Law, Faculty of Law, Maastricht University
Mr. Martin Harvey Allchurch LLM, Head of International Affairs, European Medicines Agency
Ms. Ancella Santos Quintano MSc, Senior Health Policy Officer, The European Consumers Organisation
Dr Elena Petelos, Vice President HTA, EUPHA and Co-Chair RWE & AI, HTAi
Moderated by Ms. Pramiti Parwani LLM, Law Centre for Health and Life, University of Amsterdam
Organised by Law Centre for Health and Life, the Amsterdam Centre for European Law and Governance, the Amsterdam Institute for Global Health and Development, and the EUPHA Law & Public Health section.